Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Elevation Oncology Inc (ELEV)

Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down Zacks Investment Research - Fri Oct 25, 10:18AM CDT

Alkermes plc ALKS reported adjusted earnings from continuing operations of 73 cents per share for third-quarter 2024, which missed the Zacks Consensus Estimate of 78 cents. The company had reported adjusted...

CSTL : 28.89 (+1.55%)
ELEV : 0.6025 (+3.68%)
FATE : 2.08 (-6.31%)
ALKS : 27.78 (-0.47%)
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
5 Biotech Stocks Under $10 With Multibagger Potential Barchart - Fri Jul 12, 7:50AM CDT

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

ADCT : 2.0000 (+1.01%)
$SPX : 5,927.24 (+0.17%)
RZLT : 4.95 (-1.20%)
TRVI : 2.77 (unch)
ELEV : 0.6025 (+3.68%)
CRDL : 1.5050 (-3.53%)
Buy, Sell - iStock-1331349508
Up 825% So Far in 2024, Can This Penny Stock Go Any Higher? Barchart - Wed Mar 27, 7:57AM CDT

Despite its outsized year-to-date gains, Wall Street expects this breakout penny stock to soar 55% higher, on average.

ELEV : 0.6025 (+3.68%)
$SPX : 5,927.24 (+0.17%)
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 FinancialNewsMedia - Tue Jan 9, 9:25AM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.39 (-0.71%)
AMGN : 287.44 (-0.15%)
AMAM : 28.00 (+0.07%)
ELEV : 0.6025 (+3.68%)
NKTX : 2.50 (-0.60%)
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 PR Newswire - Wed Aug 16, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements PR Newswire - Thu Aug 3, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer PR Newswire - Thu Jul 13, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)
Elevation Oncology Announces Pricing of $50 Million Public Offering PR Newswire - Thu Jun 8, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)
Elevation Oncology Announces Launch of Proposed Public Offering PR Newswire - Thu Jun 8, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

ELEV : 0.6025 (+3.68%)

Barchart Exclusives

1 EV Stock Under $10 With 25% Upside Potential Barchart - 38 minutes ago
This charging stock has been under heavy pressure lately amid concerns over the fate of EV tax credits. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot